nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—ABCB1—Mitomycin—stomach cancer	0.27	0.483	CbGbCtD
Tolvaptan—ABCB1—Irinotecan—stomach cancer	0.0692	0.124	CbGbCtD
Tolvaptan—ABCB1—Docetaxel—stomach cancer	0.0507	0.0908	CbGbCtD
Tolvaptan—CYP3A4—Irinotecan—stomach cancer	0.0415	0.0742	CbGbCtD
Tolvaptan—ABCB1—Doxorubicin—stomach cancer	0.0378	0.0677	CbGbCtD
Tolvaptan—ABCB1—Methotrexate—stomach cancer	0.0366	0.0656	CbGbCtD
Tolvaptan—CYP3A4—Docetaxel—stomach cancer	0.0304	0.0544	CbGbCtD
Tolvaptan—CYP3A4—Doxorubicin—stomach cancer	0.0226	0.0405	CbGbCtD
Tolvaptan—Dehydration—Docetaxel—stomach cancer	0.00104	0.00344	CcSEcCtD
Tolvaptan—Pulmonary embolism—Epirubicin—stomach cancer	0.00104	0.00344	CcSEcCtD
Tolvaptan—Cardiac disorder—Irinotecan—stomach cancer	0.00104	0.00344	CcSEcCtD
Tolvaptan—Hyperuricaemia—Doxorubicin—stomach cancer	0.00104	0.00343	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Docetaxel—stomach cancer	0.00102	0.00338	CcSEcCtD
Tolvaptan—Hyperkalaemia—Epirubicin—stomach cancer	0.00102	0.00338	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Doxorubicin—stomach cancer	0.00102	0.00337	CcSEcCtD
Tolvaptan—Angiopathy—Irinotecan—stomach cancer	0.00102	0.00336	CcSEcCtD
Tolvaptan—Blood creatinine increased—Capecitabine—stomach cancer	0.00101	0.00336	CcSEcCtD
Tolvaptan—Immune system disorder—Irinotecan—stomach cancer	0.00101	0.00335	CcSEcCtD
Tolvaptan—Breast disorder—Docetaxel—stomach cancer	0.00101	0.00335	CcSEcCtD
Tolvaptan—Mediastinal disorder—Irinotecan—stomach cancer	0.00101	0.00334	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Docetaxel—stomach cancer	0.00101	0.00333	CcSEcCtD
Tolvaptan—Dehydration—Capecitabine—stomach cancer	0.00101	0.00333	CcSEcCtD
Tolvaptan—Urine output increased—Methotrexate—stomach cancer	0.001	0.00332	CcSEcCtD
Tolvaptan—Ecchymosis—Methotrexate—stomach cancer	0.001	0.00332	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Capecitabine—stomach cancer	0.000989	0.00327	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Docetaxel—stomach cancer	0.000986	0.00327	CcSEcCtD
Tolvaptan—Blood uric acid increased—Doxorubicin—stomach cancer	0.000979	0.00324	CcSEcCtD
Tolvaptan—Breast disorder—Capecitabine—stomach cancer	0.000978	0.00324	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Capecitabine—stomach cancer	0.000975	0.00323	CcSEcCtD
Tolvaptan—Pulmonary embolism—Doxorubicin—stomach cancer	0.000961	0.00318	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Capecitabine—stomach cancer	0.000955	0.00316	CcSEcCtD
Tolvaptan—Hyperkalaemia—Doxorubicin—stomach cancer	0.000944	0.00313	CcSEcCtD
Tolvaptan—Ecchymosis—Epirubicin—stomach cancer	0.000939	0.00311	CcSEcCtD
Tolvaptan—Polyuria—Methotrexate—stomach cancer	0.000918	0.00304	CcSEcCtD
Tolvaptan—Ill-defined disorder—Irinotecan—stomach cancer	0.000904	0.00299	CcSEcCtD
Tolvaptan—Malaise—Irinotecan—stomach cancer	0.000878	0.00291	CcSEcCtD
Tolvaptan—Syncope—Irinotecan—stomach cancer	0.000873	0.00289	CcSEcCtD
Tolvaptan—Ecchymosis—Doxorubicin—stomach cancer	0.000869	0.00288	CcSEcCtD
Tolvaptan—Loss of consciousness—Irinotecan—stomach cancer	0.000856	0.00284	CcSEcCtD
Tolvaptan—Renal failure—Docetaxel—stomach cancer	0.000847	0.0028	CcSEcCtD
Tolvaptan—Hyperglycaemia—Capecitabine—stomach cancer	0.000844	0.00279	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Methotrexate—stomach cancer	0.000822	0.00272	CcSEcCtD
Tolvaptan—Renal failure—Capecitabine—stomach cancer	0.00082	0.00272	CcSEcCtD
Tolvaptan—Discomfort—Irinotecan—stomach cancer	0.000819	0.00271	CcSEcCtD
Tolvaptan—Anaphylactic shock—Irinotecan—stomach cancer	0.000795	0.00263	CcSEcCtD
Tolvaptan—Renal impairment—Epirubicin—stomach cancer	0.000792	0.00262	CcSEcCtD
Tolvaptan—Discomfort—Fluorouracil—stomach cancer	0.000785	0.0026	CcSEcCtD
Tolvaptan—Shock—Irinotecan—stomach cancer	0.000782	0.00259	CcSEcCtD
Tolvaptan—Nervous system disorder—Irinotecan—stomach cancer	0.000779	0.00258	CcSEcCtD
Tolvaptan—Hypoglycaemia—Epirubicin—stomach cancer	0.000773	0.00256	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Epirubicin—stomach cancer	0.000769	0.00255	CcSEcCtD
Tolvaptan—Urinary tract disorder—Docetaxel—stomach cancer	0.000764	0.00253	CcSEcCtD
Tolvaptan—Anaphylactic shock—Fluorouracil—stomach cancer	0.000761	0.00252	CcSEcCtD
Tolvaptan—Connective tissue disorder—Docetaxel—stomach cancer	0.00076	0.00252	CcSEcCtD
Tolvaptan—Urethral disorder—Docetaxel—stomach cancer	0.000758	0.00251	CcSEcCtD
Tolvaptan—Anorexia—Irinotecan—stomach cancer	0.000758	0.00251	CcSEcCtD
Tolvaptan—Hyponatraemia—Epirubicin—stomach cancer	0.000757	0.00251	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Epirubicin—stomach cancer	0.000754	0.0025	CcSEcCtD
Tolvaptan—Nervous system disorder—Fluorouracil—stomach cancer	0.000747	0.00247	CcSEcCtD
Tolvaptan—Urinary tract disorder—Capecitabine—stomach cancer	0.000739	0.00245	CcSEcCtD
Tolvaptan—Connective tissue disorder—Capecitabine—stomach cancer	0.000736	0.00244	CcSEcCtD
Tolvaptan—Urethral disorder—Capecitabine—stomach cancer	0.000734	0.00243	CcSEcCtD
Tolvaptan—Renal impairment—Doxorubicin—stomach cancer	0.000733	0.00243	CcSEcCtD
Tolvaptan—Breast disorder—Methotrexate—stomach cancer	0.000728	0.00241	CcSEcCtD
Tolvaptan—Anorexia—Fluorouracil—stomach cancer	0.000726	0.0024	CcSEcCtD
Tolvaptan—Cardiac disorder—Docetaxel—stomach cancer	0.000718	0.00238	CcSEcCtD
Tolvaptan—Hypoglycaemia—Doxorubicin—stomach cancer	0.000715	0.00237	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Doxorubicin—stomach cancer	0.000712	0.00236	CcSEcCtD
Tolvaptan—Blood creatinine increased—Epirubicin—stomach cancer	0.000706	0.00234	CcSEcCtD
Tolvaptan—Angiopathy—Docetaxel—stomach cancer	0.000702	0.00232	CcSEcCtD
Tolvaptan—Dehydration—Epirubicin—stomach cancer	0.000701	0.00232	CcSEcCtD
Tolvaptan—Hyponatraemia—Doxorubicin—stomach cancer	0.000701	0.00232	CcSEcCtD
Tolvaptan—Immune system disorder—Docetaxel—stomach cancer	0.000699	0.00231	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Doxorubicin—stomach cancer	0.000698	0.00231	CcSEcCtD
Tolvaptan—Mediastinal disorder—Docetaxel—stomach cancer	0.000697	0.00231	CcSEcCtD
Tolvaptan—Cardiac disorder—Capecitabine—stomach cancer	0.000695	0.0023	CcSEcCtD
Tolvaptan—Decreased appetite—Irinotecan—stomach cancer	0.000691	0.00229	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Epirubicin—stomach cancer	0.000689	0.00228	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000686	0.00227	CcSEcCtD
Tolvaptan—Breast disorder—Epirubicin—stomach cancer	0.000681	0.00226	CcSEcCtD
Tolvaptan—Constipation—Irinotecan—stomach cancer	0.00068	0.00225	CcSEcCtD
Tolvaptan—Angiopathy—Capecitabine—stomach cancer	0.000679	0.00225	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Epirubicin—stomach cancer	0.000679	0.00225	CcSEcCtD
Tolvaptan—Immune system disorder—Capecitabine—stomach cancer	0.000676	0.00224	CcSEcCtD
Tolvaptan—Mediastinal disorder—Capecitabine—stomach cancer	0.000675	0.00224	CcSEcCtD
Tolvaptan—Malnutrition—Docetaxel—stomach cancer	0.000673	0.00223	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Epirubicin—stomach cancer	0.000665	0.0022	CcSEcCtD
Tolvaptan—Decreased appetite—Fluorouracil—stomach cancer	0.000662	0.00219	CcSEcCtD
Tolvaptan—Dysgeusia—Docetaxel—stomach cancer	0.000659	0.00218	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000657	0.00218	CcSEcCtD
Tolvaptan—Feeling abnormal—Irinotecan—stomach cancer	0.000655	0.00217	CcSEcCtD
Tolvaptan—Blood creatinine increased—Doxorubicin—stomach cancer	0.000654	0.00216	CcSEcCtD
Tolvaptan—Malnutrition—Capecitabine—stomach cancer	0.000652	0.00216	CcSEcCtD
Tolvaptan—Dehydration—Doxorubicin—stomach cancer	0.000649	0.00215	CcSEcCtD
Tolvaptan—Dysgeusia—Capecitabine—stomach cancer	0.000638	0.00211	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Doxorubicin—stomach cancer	0.000637	0.00211	CcSEcCtD
Tolvaptan—Breast disorder—Doxorubicin—stomach cancer	0.00063	0.00209	CcSEcCtD
Tolvaptan—Body temperature increased—Irinotecan—stomach cancer	0.000628	0.00208	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	0.000628	0.00208	CcSEcCtD
Tolvaptan—Feeling abnormal—Fluorouracil—stomach cancer	0.000627	0.00208	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.000615	0.00204	CcSEcCtD
Tolvaptan—Renal failure—Methotrexate—stomach cancer	0.00061	0.00202	CcSEcCtD
Tolvaptan—Ill-defined disorder—Capecitabine—stomach cancer	0.000605	0.002	CcSEcCtD
Tolvaptan—Syncope—Docetaxel—stomach cancer	0.000604	0.002	CcSEcCtD
Tolvaptan—Pollakiuria—Epirubicin—stomach cancer	0.000602	0.00199	CcSEcCtD
Tolvaptan—Body temperature increased—Fluorouracil—stomach cancer	0.000602	0.00199	CcSEcCtD
Tolvaptan—Loss of consciousness—Docetaxel—stomach cancer	0.000592	0.00196	CcSEcCtD
Tolvaptan—Hyperglycaemia—Epirubicin—stomach cancer	0.000588	0.00195	CcSEcCtD
Tolvaptan—Malaise—Capecitabine—stomach cancer	0.000588	0.00195	CcSEcCtD
Tolvaptan—Hypersensitivity—Irinotecan—stomach cancer	0.000586	0.00194	CcSEcCtD
Tolvaptan—Syncope—Capecitabine—stomach cancer	0.000585	0.00194	CcSEcCtD
Tolvaptan—Loss of consciousness—Capecitabine—stomach cancer	0.000573	0.0019	CcSEcCtD
Tolvaptan—Renal failure—Epirubicin—stomach cancer	0.000571	0.00189	CcSEcCtD
Tolvaptan—Asthenia—Irinotecan—stomach cancer	0.00057	0.00189	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000569	0.00189	CcSEcCtD
Tolvaptan—Hypersensitivity—Fluorouracil—stomach cancer	0.000561	0.00186	CcSEcCtD
Tolvaptan—Dry mouth—Docetaxel—stomach cancer	0.000561	0.00186	CcSEcCtD
Tolvaptan—Pollakiuria—Doxorubicin—stomach cancer	0.000557	0.00185	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000551	0.00183	CcSEcCtD
Tolvaptan—Urinary tract disorder—Methotrexate—stomach cancer	0.00055	0.00182	CcSEcCtD
Tolvaptan—Anaphylactic shock—Docetaxel—stomach cancer	0.000549	0.00182	CcSEcCtD
Tolvaptan—Discomfort—Capecitabine—stomach cancer	0.000548	0.00182	CcSEcCtD
Tolvaptan—Urethral disorder—Methotrexate—stomach cancer	0.000546	0.00181	CcSEcCtD
Tolvaptan—Hyperglycaemia—Doxorubicin—stomach cancer	0.000544	0.0018	CcSEcCtD
Tolvaptan—Diarrhoea—Irinotecan—stomach cancer	0.000544	0.0018	CcSEcCtD
Tolvaptan—Dry mouth—Capecitabine—stomach cancer	0.000543	0.0018	CcSEcCtD
Tolvaptan—Shock—Docetaxel—stomach cancer	0.000541	0.00179	CcSEcCtD
Tolvaptan—Nervous system disorder—Docetaxel—stomach cancer	0.000539	0.00178	CcSEcCtD
Tolvaptan—Pruritus—Fluorouracil—stomach cancer	0.000539	0.00178	CcSEcCtD
Tolvaptan—Skin disorder—Docetaxel—stomach cancer	0.000534	0.00177	CcSEcCtD
Tolvaptan—Renal failure—Doxorubicin—stomach cancer	0.000529	0.00175	CcSEcCtD
Tolvaptan—Dizziness—Irinotecan—stomach cancer	0.000526	0.00174	CcSEcCtD
Tolvaptan—Anorexia—Docetaxel—stomach cancer	0.000524	0.00173	CcSEcCtD
Tolvaptan—Shock—Capecitabine—stomach cancer	0.000523	0.00173	CcSEcCtD
Tolvaptan—Nervous system disorder—Capecitabine—stomach cancer	0.000522	0.00173	CcSEcCtD
Tolvaptan—Diarrhoea—Fluorouracil—stomach cancer	0.000521	0.00173	CcSEcCtD
Tolvaptan—Cardiac disorder—Methotrexate—stomach cancer	0.000517	0.00171	CcSEcCtD
Tolvaptan—Skin disorder—Capecitabine—stomach cancer	0.000517	0.00171	CcSEcCtD
Tolvaptan—Urinary tract disorder—Epirubicin—stomach cancer	0.000515	0.00171	CcSEcCtD
Tolvaptan—Connective tissue disorder—Epirubicin—stomach cancer	0.000513	0.0017	CcSEcCtD
Tolvaptan—Urethral disorder—Epirubicin—stomach cancer	0.000511	0.00169	CcSEcCtD
Tolvaptan—Anorexia—Capecitabine—stomach cancer	0.000507	0.00168	CcSEcCtD
Tolvaptan—Angiopathy—Methotrexate—stomach cancer	0.000506	0.00168	CcSEcCtD
Tolvaptan—Immune system disorder—Methotrexate—stomach cancer	0.000503	0.00167	CcSEcCtD
Tolvaptan—Dizziness—Fluorouracil—stomach cancer	0.000503	0.00167	CcSEcCtD
Tolvaptan—Mediastinal disorder—Methotrexate—stomach cancer	0.000502	0.00166	CcSEcCtD
Tolvaptan—Headache—Irinotecan—stomach cancer	0.000498	0.00165	CcSEcCtD
Tolvaptan—Malnutrition—Methotrexate—stomach cancer	0.000485	0.00161	CcSEcCtD
Tolvaptan—Cardiac disorder—Epirubicin—stomach cancer	0.000484	0.0016	CcSEcCtD
Tolvaptan—Decreased appetite—Docetaxel—stomach cancer	0.000478	0.00158	CcSEcCtD
Tolvaptan—Headache—Fluorouracil—stomach cancer	0.000477	0.00158	CcSEcCtD
Tolvaptan—Urinary tract disorder—Doxorubicin—stomach cancer	0.000477	0.00158	CcSEcCtD
Tolvaptan—Dysgeusia—Methotrexate—stomach cancer	0.000475	0.00157	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000474	0.00157	CcSEcCtD
Tolvaptan—Connective tissue disorder—Doxorubicin—stomach cancer	0.000474	0.00157	CcSEcCtD
Tolvaptan—Angiopathy—Epirubicin—stomach cancer	0.000473	0.00157	CcSEcCtD
Tolvaptan—Urethral disorder—Doxorubicin—stomach cancer	0.000473	0.00157	CcSEcCtD
Tolvaptan—Nausea—Irinotecan—stomach cancer	0.000472	0.00156	CcSEcCtD
Tolvaptan—Immune system disorder—Epirubicin—stomach cancer	0.000471	0.00156	CcSEcCtD
Tolvaptan—Mediastinal disorder—Epirubicin—stomach cancer	0.00047	0.00156	CcSEcCtD
Tolvaptan—Constipation—Docetaxel—stomach cancer	0.00047	0.00156	CcSEcCtD
Tolvaptan—Decreased appetite—Capecitabine—stomach cancer	0.000462	0.00153	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000459	0.00152	CcSEcCtD
Tolvaptan—Constipation—Capecitabine—stomach cancer	0.000455	0.00151	CcSEcCtD
Tolvaptan—Malnutrition—Epirubicin—stomach cancer	0.000454	0.0015	CcSEcCtD
Tolvaptan—Feeling abnormal—Docetaxel—stomach cancer	0.000453	0.0015	CcSEcCtD
Tolvaptan—Nausea—Fluorouracil—stomach cancer	0.000452	0.0015	CcSEcCtD
Tolvaptan—Ill-defined disorder—Methotrexate—stomach cancer	0.00045	0.00149	CcSEcCtD
Tolvaptan—Cardiac disorder—Doxorubicin—stomach cancer	0.000448	0.00148	CcSEcCtD
Tolvaptan—Dysgeusia—Epirubicin—stomach cancer	0.000445	0.00147	CcSEcCtD
Tolvaptan—Feeling abnormal—Capecitabine—stomach cancer	0.000438	0.00145	CcSEcCtD
Tolvaptan—Angiopathy—Doxorubicin—stomach cancer	0.000438	0.00145	CcSEcCtD
Tolvaptan—Malaise—Methotrexate—stomach cancer	0.000438	0.00145	CcSEcCtD
Tolvaptan—Immune system disorder—Doxorubicin—stomach cancer	0.000436	0.00144	CcSEcCtD
Tolvaptan—Mediastinal disorder—Doxorubicin—stomach cancer	0.000435	0.00144	CcSEcCtD
Tolvaptan—Body temperature increased—Docetaxel—stomach cancer	0.000434	0.00144	CcSEcCtD
Tolvaptan—Ill-defined disorder—Epirubicin—stomach cancer	0.000421	0.0014	CcSEcCtD
Tolvaptan—Body temperature increased—Capecitabine—stomach cancer	0.000421	0.00139	CcSEcCtD
Tolvaptan—Malnutrition—Doxorubicin—stomach cancer	0.00042	0.00139	CcSEcCtD
Tolvaptan—Dysgeusia—Doxorubicin—stomach cancer	0.000411	0.00136	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00041	0.00136	CcSEcCtD
Tolvaptan—Malaise—Epirubicin—stomach cancer	0.00041	0.00136	CcSEcCtD
Tolvaptan—Discomfort—Methotrexate—stomach cancer	0.000408	0.00135	CcSEcCtD
Tolvaptan—Syncope—Epirubicin—stomach cancer	0.000407	0.00135	CcSEcCtD
Tolvaptan—Hypersensitivity—Docetaxel—stomach cancer	0.000405	0.00134	CcSEcCtD
Tolvaptan—Loss of consciousness—Epirubicin—stomach cancer	0.000399	0.00132	CcSEcCtD
Tolvaptan—Anaphylactic shock—Methotrexate—stomach cancer	0.000396	0.00131	CcSEcCtD
Tolvaptan—Asthenia—Docetaxel—stomach cancer	0.000394	0.00131	CcSEcCtD
Tolvaptan—Hypersensitivity—Capecitabine—stomach cancer	0.000392	0.0013	CcSEcCtD
Tolvaptan—Ill-defined disorder—Doxorubicin—stomach cancer	0.00039	0.00129	CcSEcCtD
Tolvaptan—Pruritus—Docetaxel—stomach cancer	0.000389	0.00129	CcSEcCtD
Tolvaptan—Nervous system disorder—Methotrexate—stomach cancer	0.000388	0.00129	CcSEcCtD
Tolvaptan—Skin disorder—Methotrexate—stomach cancer	0.000385	0.00127	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000384	0.00127	CcSEcCtD
Tolvaptan—Discomfort—Epirubicin—stomach cancer	0.000382	0.00127	CcSEcCtD
Tolvaptan—Asthenia—Capecitabine—stomach cancer	0.000382	0.00126	CcSEcCtD
Tolvaptan—Malaise—Doxorubicin—stomach cancer	0.000379	0.00125	CcSEcCtD
Tolvaptan—Dry mouth—Epirubicin—stomach cancer	0.000378	0.00125	CcSEcCtD
Tolvaptan—Anorexia—Methotrexate—stomach cancer	0.000377	0.00125	CcSEcCtD
Tolvaptan—Syncope—Doxorubicin—stomach cancer	0.000377	0.00125	CcSEcCtD
Tolvaptan—Pruritus—Capecitabine—stomach cancer	0.000376	0.00125	CcSEcCtD
Tolvaptan—Diarrhoea—Docetaxel—stomach cancer	0.000376	0.00125	CcSEcCtD
Tolvaptan—Anaphylactic shock—Epirubicin—stomach cancer	0.000371	0.00123	CcSEcCtD
Tolvaptan—Loss of consciousness—Doxorubicin—stomach cancer	0.000369	0.00122	CcSEcCtD
Tolvaptan—Shock—Epirubicin—stomach cancer	0.000365	0.00121	CcSEcCtD
Tolvaptan—Diarrhoea—Capecitabine—stomach cancer	0.000364	0.00121	CcSEcCtD
Tolvaptan—Nervous system disorder—Epirubicin—stomach cancer	0.000363	0.0012	CcSEcCtD
Tolvaptan—Dizziness—Docetaxel—stomach cancer	0.000363	0.0012	CcSEcCtD
Tolvaptan—Skin disorder—Epirubicin—stomach cancer	0.00036	0.00119	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000355	0.00118	CcSEcCtD
Tolvaptan—Discomfort—Doxorubicin—stomach cancer	0.000353	0.00117	CcSEcCtD
Tolvaptan—Anorexia—Epirubicin—stomach cancer	0.000353	0.00117	CcSEcCtD
Tolvaptan—Dizziness—Capecitabine—stomach cancer	0.000352	0.00117	CcSEcCtD
Tolvaptan—Dry mouth—Doxorubicin—stomach cancer	0.00035	0.00116	CcSEcCtD
Tolvaptan—Decreased appetite—Methotrexate—stomach cancer	0.000344	0.00114	CcSEcCtD
Tolvaptan—Headache—Docetaxel—stomach cancer	0.000344	0.00114	CcSEcCtD
Tolvaptan—Anaphylactic shock—Doxorubicin—stomach cancer	0.000343	0.00114	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000342	0.00113	CcSEcCtD
Tolvaptan—Shock—Doxorubicin—stomach cancer	0.000337	0.00112	CcSEcCtD
Tolvaptan—Nervous system disorder—Doxorubicin—stomach cancer	0.000336	0.00111	CcSEcCtD
Tolvaptan—Headache—Capecitabine—stomach cancer	0.000333	0.0011	CcSEcCtD
Tolvaptan—Skin disorder—Doxorubicin—stomach cancer	0.000333	0.0011	CcSEcCtD
Tolvaptan—Anorexia—Doxorubicin—stomach cancer	0.000327	0.00108	CcSEcCtD
Tolvaptan—Nausea—Docetaxel—stomach cancer	0.000326	0.00108	CcSEcCtD
Tolvaptan—Feeling abnormal—Methotrexate—stomach cancer	0.000326	0.00108	CcSEcCtD
Tolvaptan—Decreased appetite—Epirubicin—stomach cancer	0.000322	0.00107	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Epirubicin—stomach cancer	0.00032	0.00106	CcSEcCtD
Tolvaptan—Constipation—Epirubicin—stomach cancer	0.000317	0.00105	CcSEcCtD
Tolvaptan—Nausea—Capecitabine—stomach cancer	0.000316	0.00105	CcSEcCtD
Tolvaptan—Body temperature increased—Methotrexate—stomach cancer	0.000313	0.00104	CcSEcCtD
Tolvaptan—Feeling abnormal—Epirubicin—stomach cancer	0.000305	0.00101	CcSEcCtD
Tolvaptan—Decreased appetite—Doxorubicin—stomach cancer	0.000298	0.000987	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000296	0.000981	CcSEcCtD
Tolvaptan—Constipation—Doxorubicin—stomach cancer	0.000293	0.000971	CcSEcCtD
Tolvaptan—Body temperature increased—Epirubicin—stomach cancer	0.000293	0.00097	CcSEcCtD
Tolvaptan—Hypersensitivity—Methotrexate—stomach cancer	0.000292	0.000966	CcSEcCtD
Tolvaptan—Asthenia—Methotrexate—stomach cancer	0.000284	0.000941	CcSEcCtD
Tolvaptan—Feeling abnormal—Doxorubicin—stomach cancer	0.000283	0.000936	CcSEcCtD
Tolvaptan—Pruritus—Methotrexate—stomach cancer	0.00028	0.000928	CcSEcCtD
Tolvaptan—Hypersensitivity—Epirubicin—stomach cancer	0.000273	0.000904	CcSEcCtD
Tolvaptan—Body temperature increased—Doxorubicin—stomach cancer	0.000271	0.000898	CcSEcCtD
Tolvaptan—Diarrhoea—Methotrexate—stomach cancer	0.000271	0.000897	CcSEcCtD
Tolvaptan—Asthenia—Epirubicin—stomach cancer	0.000266	0.000881	CcSEcCtD
Tolvaptan—Pruritus—Epirubicin—stomach cancer	0.000262	0.000868	CcSEcCtD
Tolvaptan—Dizziness—Methotrexate—stomach cancer	0.000262	0.000867	CcSEcCtD
Tolvaptan—Diarrhoea—Epirubicin—stomach cancer	0.000254	0.00084	CcSEcCtD
Tolvaptan—Hypersensitivity—Doxorubicin—stomach cancer	0.000253	0.000837	CcSEcCtD
Tolvaptan—Headache—Methotrexate—stomach cancer	0.000248	0.000822	CcSEcCtD
Tolvaptan—Asthenia—Doxorubicin—stomach cancer	0.000246	0.000815	CcSEcCtD
Tolvaptan—Dizziness—Epirubicin—stomach cancer	0.000245	0.000812	CcSEcCtD
Tolvaptan—Pruritus—Doxorubicin—stomach cancer	0.000243	0.000804	CcSEcCtD
Tolvaptan—Nausea—Methotrexate—stomach cancer	0.000235	0.000779	CcSEcCtD
Tolvaptan—Diarrhoea—Doxorubicin—stomach cancer	0.000235	0.000777	CcSEcCtD
Tolvaptan—Headache—Epirubicin—stomach cancer	0.000232	0.000769	CcSEcCtD
Tolvaptan—Dizziness—Doxorubicin—stomach cancer	0.000227	0.000751	CcSEcCtD
Tolvaptan—Nausea—Epirubicin—stomach cancer	0.00022	0.000729	CcSEcCtD
Tolvaptan—Headache—Doxorubicin—stomach cancer	0.000215	0.000712	CcSEcCtD
Tolvaptan—Nausea—Doxorubicin—stomach cancer	0.000204	0.000675	CcSEcCtD
Tolvaptan—AVPR2—Signaling Pathways—BMP2—stomach cancer	0.000138	0.00099	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—F2R—stomach cancer	0.000138	0.00099	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKR1C3—stomach cancer	0.000137	0.000981	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKR1C3—stomach cancer	0.000136	0.000974	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HTR1A—stomach cancer	0.000135	0.000971	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HTR1A—stomach cancer	0.000135	0.000964	CbGpPWpGaD
Tolvaptan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—stomach cancer	0.000134	0.000959	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—JUN—stomach cancer	0.000131	0.00094	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PRKCB—stomach cancer	0.000131	0.00094	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ANXA1—stomach cancer	0.000131	0.000937	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PRKCB—stomach cancer	0.00013	0.000933	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ANXA1—stomach cancer	0.00013	0.000931	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ADRB1—stomach cancer	0.000127	0.000908	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ADRB1—stomach cancer	0.000126	0.000901	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CXCL8—stomach cancer	0.000122	0.000876	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RPS6—stomach cancer	0.000121	0.000867	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RPS6—stomach cancer	0.00012	0.000861	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PRKCB—stomach cancer	0.000119	0.000853	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6ST—stomach cancer	0.000119	0.00085	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PRKCB—stomach cancer	0.000118	0.000847	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6ST—stomach cancer	0.000118	0.000844	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL1B—stomach cancer	0.000117	0.00084	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTT1—stomach cancer	0.000116	0.000831	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	0.000116	0.000828	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	0.000115	0.000822	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—stomach cancer	0.000115	0.000821	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	0.000114	0.000814	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ACAD8—stomach cancer	0.000112	0.000804	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	0.000112	0.000799	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HBEGF—stomach cancer	0.000111	0.000797	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HBEGF—stomach cancer	0.00011	0.000791	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	0.00011	0.000788	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6R—stomach cancer	0.000106	0.000758	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—RHOA—stomach cancer	0.000105	0.000754	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6R—stomach cancer	0.000105	0.000753	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—RHOA—stomach cancer	0.000105	0.000749	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000104	0.000747	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ADRB2—stomach cancer	0.000103	0.000736	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ADRB2—stomach cancer	0.000102	0.00073	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PPP2R1A—stomach cancer	0.000101	0.000721	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GMPR2—stomach cancer	0.0001	0.000717	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PPP2R1A—stomach cancer	9.99e-05	0.000716	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—VEGFA—stomach cancer	9.93e-05	0.000711	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—RHOA—stomach cancer	9.56e-05	0.000685	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—RHOA—stomach cancer	9.49e-05	0.00068	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SMAD4—stomach cancer	9.34e-05	0.000669	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SMAD4—stomach cancer	9.28e-05	0.000664	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—CXCL8—stomach cancer	9.25e-05	0.000662	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—CXCL8—stomach cancer	9.18e-05	0.000657	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SUCLG1—stomach cancer	9.15e-05	0.000655	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—IDH3B—stomach cancer	9.15e-05	0.000655	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FYN—stomach cancer	8.87e-05	0.000635	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FYN—stomach cancer	8.81e-05	0.000631	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	8.7e-05	0.000623	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—stomach cancer	8.51e-05	0.000609	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NDUFV1—stomach cancer	8.51e-05	0.000609	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NDUFS1—stomach cancer	8.51e-05	0.000609	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CXCL8—stomach cancer	8.4e-05	0.000601	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CXCL8—stomach cancer	8.34e-05	0.000597	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FGFR2—stomach cancer	8.33e-05	0.000597	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FGFR2—stomach cancer	8.27e-05	0.000592	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	8.19e-05	0.000587	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTP1—stomach cancer	8.04e-05	0.000576	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	7.93e-05	0.000568	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	7.63e-05	0.000546	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IRS2—stomach cancer	7.63e-05	0.000546	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—BLVRB—stomach cancer	7.58e-05	0.000543	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PGLS—stomach cancer	7.58e-05	0.000543	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IRS2—stomach cancer	7.57e-05	0.000542	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CAV1—stomach cancer	7.39e-05	0.00053	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTM1—stomach cancer	7.39e-05	0.000529	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOA1—stomach cancer	7.38e-05	0.000528	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CAV1—stomach cancer	7.34e-05	0.000526	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOA1—stomach cancer	7.32e-05	0.000525	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	7.29e-05	0.000522	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPAP2A—stomach cancer	7.23e-05	0.000518	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PRKCB—stomach cancer	7.04e-05	0.000504	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6ST—stomach cancer	7.01e-05	0.000502	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PRKCB—stomach cancer	6.99e-05	0.000501	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6ST—stomach cancer	6.96e-05	0.000499	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ACAD8—stomach cancer	6.91e-05	0.000495	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APC—stomach cancer	6.74e-05	0.000482	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APC—stomach cancer	6.69e-05	0.000479	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—MAPK3—stomach cancer	6.45e-05	0.000462	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CKB—stomach cancer	6.45e-05	0.000462	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—FBP1—stomach cancer	6.45e-05	0.000462	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CA1—stomach cancer	6.45e-05	0.000462	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NDUFA2—stomach cancer	6.45e-05	0.000462	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—MAPK3—stomach cancer	6.4e-05	0.000459	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	6.36e-05	0.000456	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6R—stomach cancer	6.25e-05	0.000448	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	6.22e-05	0.000445	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6R—stomach cancer	6.21e-05	0.000445	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GMPR2—stomach cancer	6.16e-05	0.000441	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—MAPK1—stomach cancer	6.14e-05	0.00044	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—EGFR—stomach cancer	6.14e-05	0.00044	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—MAPK1—stomach cancer	6.09e-05	0.000436	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—EGFR—stomach cancer	6.09e-05	0.000436	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLIN2—stomach cancer	6.06e-05	0.000434	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CA2—stomach cancer	5.9e-05	0.000422	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	5.89e-05	0.000422	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PIK3CA—stomach cancer	5.86e-05	0.00042	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SERPINE1—stomach cancer	5.86e-05	0.000419	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—PIK3CA—stomach cancer	5.82e-05	0.000417	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SERPINE1—stomach cancer	5.81e-05	0.000416	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—KRAS—stomach cancer	5.8e-05	0.000415	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—KRAS—stomach cancer	5.76e-05	0.000412	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NT5E—stomach cancer	5.75e-05	0.000412	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PGAM1—stomach cancer	5.75e-05	0.000412	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RHOA—stomach cancer	5.65e-05	0.000405	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—IDH3B—stomach cancer	5.64e-05	0.000404	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SUCLG1—stomach cancer	5.64e-05	0.000404	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	5.62e-05	0.000403	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RHOA—stomach cancer	5.61e-05	0.000402	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	5.61e-05	0.000402	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOS3—stomach cancer	5.59e-05	0.0004	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOS3—stomach cancer	5.55e-05	0.000398	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALDH7A1—stomach cancer	5.48e-05	0.000393	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLCE1—stomach cancer	5.48e-05	0.000393	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	5.44e-05	0.000389	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PIK3CA—stomach cancer	5.33e-05	0.000381	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	5.31e-05	0.00038	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PIK3CA—stomach cancer	5.29e-05	0.000379	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—UMPS—stomach cancer	5.25e-05	0.000376	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NDUFS1—stomach cancer	5.24e-05	0.000375	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NDUFV1—stomach cancer	5.24e-05	0.000375	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ERBB2—stomach cancer	5.23e-05	0.000375	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ERBB2—stomach cancer	5.19e-05	0.000372	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CXCL8—stomach cancer	4.96e-05	0.000355	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—HRAS—stomach cancer	4.93e-05	0.000353	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL8—stomach cancer	4.92e-05	0.000353	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	4.9e-05	0.000351	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—HRAS—stomach cancer	4.89e-05	0.00035	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ECHS1—stomach cancer	4.89e-05	0.00035	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PDHA1—stomach cancer	4.89e-05	0.00035	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDKN1B—stomach cancer	4.84e-05	0.000347	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDKN1B—stomach cancer	4.81e-05	0.000344	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—stomach cancer	4.72e-05	0.000338	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	4.7e-05	0.000337	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—stomach cancer	4.68e-05	0.000335	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PGLS—stomach cancer	4.67e-05	0.000335	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—BLVRB—stomach cancer	4.67e-05	0.000335	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	4.63e-05	0.000332	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCND1—stomach cancer	4.62e-05	0.000331	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—JUN—stomach cancer	4.61e-05	0.00033	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TYMP—stomach cancer	4.59e-05	0.000329	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—FADS1—stomach cancer	4.59e-05	0.000329	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCND1—stomach cancer	4.59e-05	0.000329	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—JUN—stomach cancer	4.58e-05	0.000328	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	4.51e-05	0.000323	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP9—stomach cancer	4.49e-05	0.000321	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDKN1A—stomach cancer	4.47e-05	0.00032	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPAP2A—stomach cancer	4.46e-05	0.000319	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP9—stomach cancer	4.45e-05	0.000319	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDKN1A—stomach cancer	4.44e-05	0.000318	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	4.41e-05	0.000316	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	4.41e-05	0.000316	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK8—stomach cancer	4.36e-05	0.000313	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK8—stomach cancer	4.33e-05	0.00031	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SREBF2—stomach cancer	4.3e-05	0.000308	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—RORA—stomach cancer	4.25e-05	0.000304	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	4.2e-05	0.000301	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	4.16e-05	0.000298	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—stomach cancer	4.03e-05	0.000289	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—stomach cancer	4e-05	0.000286	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—STAT3—stomach cancer	3.99e-05	0.000286	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALDOB—stomach cancer	3.98e-05	0.000285	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NDUFA2—stomach cancer	3.97e-05	0.000284	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—FBP1—stomach cancer	3.97e-05	0.000284	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CA1—stomach cancer	3.97e-05	0.000284	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CKB—stomach cancer	3.97e-05	0.000284	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—STAT3—stomach cancer	3.96e-05	0.000284	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	3.83e-05	0.000274	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK3—stomach cancer	3.81e-05	0.000273	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK3—stomach cancer	3.78e-05	0.000271	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLIN2—stomach cancer	3.73e-05	0.000267	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MYC—stomach cancer	3.71e-05	0.000265	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALOX5—stomach cancer	3.7e-05	0.000265	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.7e-05	0.000265	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MYC—stomach cancer	3.68e-05	0.000264	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—DPYD—stomach cancer	3.64e-05	0.000261	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CA2—stomach cancer	3.63e-05	0.00026	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MAPK1—stomach cancer	3.63e-05	0.00026	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EGFR—stomach cancer	3.63e-05	0.00026	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MAPK1—stomach cancer	3.6e-05	0.000258	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EGFR—stomach cancer	3.6e-05	0.000258	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	3.56e-05	0.000255	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NT5E—stomach cancer	3.54e-05	0.000254	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PGAM1—stomach cancer	3.54e-05	0.000254	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KRAS—stomach cancer	3.42e-05	0.000245	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KRAS—stomach cancer	3.4e-05	0.000244	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALDH7A1—stomach cancer	3.38e-05	0.000242	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLCE1—stomach cancer	3.38e-05	0.000242	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—UMPS—stomach cancer	3.24e-05	0.000232	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTT1—stomach cancer	3.22e-05	0.000231	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2A6—stomach cancer	3.18e-05	0.000228	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3CA—stomach cancer	3.15e-05	0.000225	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3CA—stomach cancer	3.12e-05	0.000224	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKR1C3—stomach cancer	3.1e-05	0.000222	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TP53—stomach cancer	3.04e-05	0.000218	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TP53—stomach cancer	3.02e-05	0.000216	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ENO1—stomach cancer	3.02e-05	0.000216	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PDHA1—stomach cancer	3.01e-05	0.000216	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ECHS1—stomach cancer	3.01e-05	0.000216	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HRAS—stomach cancer	2.91e-05	0.000208	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HRAS—stomach cancer	2.89e-05	0.000207	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TYMP—stomach cancer	2.83e-05	0.000203	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—FADS1—stomach cancer	2.83e-05	0.000203	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	2.82e-05	0.000202	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—stomach cancer	2.79e-05	0.0002	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—stomach cancer	2.77e-05	0.000198	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CD44—stomach cancer	2.68e-05	0.000192	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SREBF2—stomach cancer	2.65e-05	0.00019	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—RORA—stomach cancer	2.62e-05	0.000188	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALDOB—stomach cancer	2.45e-05	0.000176	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALOX5—stomach cancer	2.28e-05	0.000163	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPP2R1A—stomach cancer	2.28e-05	0.000163	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—DPYD—stomach cancer	2.24e-05	0.000161	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTP1—stomach cancer	2.23e-05	0.00016	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HMOX1—stomach cancer	2.2e-05	0.000158	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TYMS—stomach cancer	2.08e-05	0.000149	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTM1—stomach cancer	2.05e-05	0.000147	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTT1—stomach cancer	1.98e-05	0.000142	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.96e-05	0.000141	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ERCC2—stomach cancer	1.93e-05	0.000138	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.91e-05	0.000137	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ENO1—stomach cancer	1.86e-05	0.000133	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTHFR—stomach cancer	1.81e-05	0.00013	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CAV1—stomach cancer	1.67e-05	0.00012	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOA1—stomach cancer	1.67e-05	0.00012	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CD44—stomach cancer	1.65e-05	0.000118	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARG—stomach cancer	1.47e-05	0.000105	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.4e-05	0.0001	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTP1—stomach cancer	1.38e-05	9.85e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMOX1—stomach cancer	1.36e-05	9.72e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALB—stomach cancer	1.32e-05	9.47e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TYMS—stomach cancer	1.28e-05	9.16e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NOS3—stomach cancer	1.26e-05	9.06e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTM1—stomach cancer	1.26e-05	9.05e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ERCC2—stomach cancer	1.19e-05	8.51e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—stomach cancer	1.16e-05	8.28e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTHFR—stomach cancer	1.12e-05	8e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CAV1—stomach cancer	1.03e-05	7.38e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOA1—stomach cancer	1.03e-05	7.36e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARG—stomach cancer	9.06e-06	6.49e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALB—stomach cancer	8.15e-06	5.83e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NOS3—stomach cancer	7.79e-06	5.58e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—stomach cancer	7.13e-06	5.1e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3CA—stomach cancer	7.12e-06	5.1e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3CA—stomach cancer	4.38e-06	3.14e-05	CbGpPWpGaD
